ArticleBMC pediatrics2025
Serum magnesium levels of children living with sickle cell anaemia at the Lagos University Teaching Hospital: a comparative cross-sectional study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSickle cell anaemia (SCA) is a lifelong, chronic haemolytic disorder with episodic vaso-occlusive crises (VOC) and chronic end-organ damage. Red cell dehydration during a VOC changes permeability with loss of potassium and magnesium. Magnesium has been found to act via both Gardos and K-Cl channels, preventing red cell dehydration and reducing the propensity for sickling. This study assessed serum magnesium levels in children living with SCA in steady state and crisis, and the relationship between serum magnesium levels and severity of pain in VOC.
methodsA comparative cross-sectional study involving age- and gender-matched 180 children living with SCA aged 1-18 years (90 in VOC and steady state, respectively). The severity of pain was assessed using standard pain tools (FLACC and Wong-Baker FACES Pain scale), and a blood sample was taken for magnesium assay using the colorimetry method of analysis. Categorical variables were presented as frequencies and percentages. Comparison of means between the two groups and according to magnesium status was carried out using an independent Student's t-test.
resultsThe mean age of participants in VOC and steady state was 8.49 ± 2.4 years and 8.62 ± 2.0 years, respectively. The mean serum magnesium of subjects in VOC was significantly higher compared to the steady state (0.85 ± 0.1 vs 0.83 ± 0.1 mmol/l, p = 0.032). The moderate to severe pain was the most common pain (63.3%), and the average serum magnesium was higher in the group with moderate to severe pain, but the difference was not statistically significant across the three groups (p = 0.315).
conclusionVOC maybe associated with elevated serum magnesium in SCA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.